{"id":17915,"date":"2026-03-06T10:58:12","date_gmt":"2026-03-06T10:58:12","guid":{"rendered":"https:\/\/www.colorectalcancercanada.com\/?post_type=drug&#038;p=17915"},"modified":"2026-03-06T11:07:24","modified_gmt":"2026-03-06T11:07:24","slug":"fruquintinib","status":"publish","type":"drug","link":"https:\/\/www.colorectalcancercanada.com\/fr\/drug\/fruquintinib\/","title":{"rendered":"Fruquintinib"},"content":{"rendered":"<p><strong>Indication<\/strong><\/p>\n<p>Pour le traitement des patients adultes atteints d&rsquo;un cancer colorectal m\u00e9tastatique (mCRC) qui ont d\u00e9j\u00e0 \u00e9t\u00e9 trait\u00e9s ou qui ne sont pas consid\u00e9r\u00e9s comme candidats aux traitements standard disponibles, notamment la chimioth\u00e9rapie \u00e0 base de fluoropyrimidine, d&rsquo;oxaliplatine et d&rsquo;irinot\u00e9can, un agent anti-VEGF, un agent anti-EGFR (si RAS de type sauvage) et soit la trifluridine-tipiracil, soit le r\u00e9goraf\u00e9nib.<\/p>\n","protected":false},"template":"","crc_subtype":[401],"drug_stage":[402],"therapy_line":[],"health_canada_approval":[404],"cda_review":[405],"cda_recommendation":[406],"inesss_review":[407],"inesss_recommendation":[408],"pcpa_status":[409],"public_reimbursement":[411,410,414,413,412],"class_list":["post-17915","drug","type-drug","status-publish","hentry","crc_subtype-none-fr","drug_stage-iv-fr","health_canada_approval-approved-fr","cda_review-completed-fr","cda_recommendation-positive-fr","inesss_review-termine-fr","inesss_recommendation-positive-fr","pcpa_status-completed-fr","public_reimbursement-alberta-fr","public_reimbursement-colombie-britannique-fr","public_reimbursement-ns-fr","public_reimbursement-qc-fr","public_reimbursement-sk-fr"],"_links":{"self":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug\/17915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug"}],"about":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/types\/drug"}],"wp:attachment":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media?parent=17915"}],"wp:term":[{"taxonomy":"crc_subtype","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/crc_subtype?post=17915"},{"taxonomy":"drug_stage","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug_stage?post=17915"},{"taxonomy":"therapy_line","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/therapy_line?post=17915"},{"taxonomy":"health_canada_approval","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/health_canada_approval?post=17915"},{"taxonomy":"cda_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_review?post=17915"},{"taxonomy":"cda_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_recommendation?post=17915"},{"taxonomy":"inesss_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_review?post=17915"},{"taxonomy":"inesss_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_recommendation?post=17915"},{"taxonomy":"pcpa_status","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/pcpa_status?post=17915"},{"taxonomy":"public_reimbursement","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/public_reimbursement?post=17915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}